Scotts Miracle-Gro (SMG) expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug. “Increased capital investments by cannabis companies could positively impact ScottsMiracle-Gro’s Hawthorne Gardening Company subsidiary, which provides nutrients, lighting and other supplies to legal cannabis growing operations. Hawthorne has seen the level of capital spending on its products decline in recent years as cannabis companies have faced financial struggles. Rescheduling does not alter ScottsMiracle-Gro’s plan to strategically move Hawthorne into a cannabis-dedicated company as part of the broader strategy to focus on the growth of its core consumer lawn and garden business. The company expects to combine Hawthorne with a cannabis company early in fiscal 2026,” the company stated. “Reclassifying cannabis will set Hawthorne up for greater growth opportunities moving forward and make it a more attractive partner to a cannabis-dedicated company,” said Chairman and CEO Jim Hagedorn.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- Scotts Miracle-Gro CEO expresses support for cannabis rescheduling order
- Scotts Miracle-Gro: Strong Buy Recommendation Based on Promising Growth Projections and Valuation Upside
- Scotts Miracle-Gro Faces Financial Uncertainty Amid U.S. Legislative Challenges
- Scotts Miracle-Gro, Columbus Crew expand long-standing partnership
- Scotts Miracle-Gro Secures $2 Billion Loan Facilities